Australia's most trusted
source of pharma news
Thursday, 25 April 2024
Posted 26 May 2022 PM
The TGA has been accused of tokenism for delisting just one of Cat Media's controversial weight-loss products while allowing another nine carrying the same Fatblaster brand name to continue to be sold.
Friends of Science in Medicine President, Ken Harvey, has urged the TGA to demand evidence supporting promotional claims for all 10 products and if lacking, delist the entire class.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.